DV
Dividend Vision

ETF Comparison

HLTH vs IHI: Which Is the Better Pick in 2026?

A head-to-head comparison of Tema Healthcare AI ETF and iShares U.S. Medical Devices ETF covering yield, cost, risk, and income potential.

Data updated July 24, 2026

ETFs12
Total AUM$3.60B

ETFs and AUM reflect what Dividend Vision tracks — the issuer's full lineup may be larger.

Tema ETFs specializes in thematic investing, focusing on innovative sectors and mega-trends rather than traditional asset classes. The firm's current lineup consists of a single actively managed fund, the NASA ETF (NASDAQ: NASA), which targets companies involved in space exploration, satellite technology, and related aerospace industries. This niche approach appeals to investors seeking concentrated exposure to emerging technology themes beyond conventional dividend or income strategies.

See our curated list of related YouTube videos on HLTH.

ETFs477
Total AUM$4543B

ETFs and AUM reflect what Dividend Vision tracks — the issuer's full lineup may be larger.

iShares is one of the largest ETF providers globally, known for offering a broad, diversified lineup of exchange-traded funds across multiple asset classes and investment strategies. The company operates 215 funds spanning 15 distinct families, including popular offerings in dividend income, covered call strategies, bonds, equities, ESG-focused investments, and factor-based approaches, with widely-held tickers like AGG (bond), ACWI (global equity), and AOA (allocation). iShares is characterized by its comprehensive fund ecosystem that serves both core portfolio holdings and specialized investment strategies, making it a prominent player for investors seeking both traditional and alternative income-generating ETF solutions.

See our curated list of related YouTube videos on IHI.

Side-by-side snapshot

HLTHIHI
Full nameTema Healthcare AI ETFiShares U.S. Medical Devices ETF
IssuerTema ETFsiShares
Last Close$25.26 as of July 24, 2026$49.44 as of July 24, 2026
Distribution yield0.61%
Distribution Safety Score™ 81
Expense ratio0.75%0.40%
AUM$3.08B
Distribution frequencyQuarterly
Underlying index
ObjectiveSeeks long-term capital appreciation through an actively managed portfolio of companies applying artificial intelligence across healthcare — including AI-driven drug discovery, diagnostics, medical imaging, medical devices, and healthcare IT platforms.
Asset classEquityEquity
Inception date07/21/202605/01/2006
Beta1.0860.82
Last dividend$0.0750
Ex-dividend date06/15/2026

— Distribution yield, last dividend, and ex-dividend date are not yet available because HLTH launched July 2026; these fields will populate after the first distribution.

Bottom lineChoose HLTH if you want broad equity exposure. Choose IHI if you want higher current income (0.61% while HLTH makes no distribution).

Income calculator

See how much monthly income a hypothetical investment would generate in each ETF at current yields.

Want to go deeper?

Add these ETFs to a sample portfolio and forecast your dividend income over 5+ years — no signup required.

Visual comparison

Key metrics

Projected income on $10K

Projections assume the current yield and share price remain constant. Actual results will vary.

Quick verdict

HLTH (Tema Healthcare AI ETF) and IHI (iShares U.S. Medical Devices ETF) are both ETFs, but they take different approaches.

IHI currently shows a 0.61% distribution yield. HLTH has not yet established a full distribution history, so a comparable yield figure is not available.

IHI is cheaper with an expense ratio of 0.40% compared to 0.75%.

Deep dive

Yield & income

On a $10,000 investment, HLTH has no reported distribution yield yet, so a monthly income estimate is not available, while IHI would produce $5.08/month, at current distribution rates.

HLTH yield
IHI yield0.61%

Cost & efficiency

Over 10 years on $10,000, HLTH would cost approximately $750 in fees vs $400 for IHI (simplified, not compounded). The $350.00 difference may be offset by yield or performance.

HLTH ER0.75%
IHI ER0.40%

Strategy & risk

HLTH is an ETF, while IHI is an ETF. Beta is 1.086 for HLTH and 0.82 for IHI, indicating IHI is less volatile relative to the market.

HLTH beta1.086
IHI beta0.82

Fund details

HLTH is managed by Tema ETFs (launched 07/21/2026). IHI is managed by iShares (launched 05/01/2006) with $3.08B in assets.

IHI AUM$3.08B

Enjoyed this page?

Do us a favor — if you found this comparison useful, please share it with a friend researching dividend ETFs.

Frequently asked questions

Which of HLTH or IHI pays more dividend income?

IHI currently reports a distribution yield, while HLTH has not yet established a full distribution history. A direct income comparison is not yet meaningful — check back once both funds have published several consecutive distributions.

What is the difference between HLTH and IHI?

HLTH (Tema Healthcare AI ETF) is an ETF, while IHI (iShares U.S. Medical Devices ETF) is an ETF. They are issued by Tema ETFs and iShares respectively.

Can I hold both HLTH and IHI?

Yes — nothing prevents holding both. Whether the combination actually diversifies depends on how much the underlying exposures overlap, which isn't fully measurable from the data on this page; review each security's holdings, sector, and strategy before treating them as complementary.

Which has lower fees, HLTH or IHI?

HLTH has an expense ratio of 0.75% while IHI charges 0.40%. Lower fees mean more of your investment returns stay in your pocket over time.

How much income does $10,000 in HLTH vs IHI generate?

At current rates, HLTH has not established a distribution history yet, so a monthly income estimate is not available. The same in IHI would produce about $5.08 per month ($61.00 annually).

More comparisons to explore

People also compare HLTH with

People also compare IHI with

Popular comparisons

Learn the method

The metrics behind this comparison, explained in the Academy.

Still deciding? Compare them against your own portfolio

See how each ETF fits alongside your real holdings — forecast future income, analyze overlap, and gauge risk. Start a free 7-day Dividend Vision trial and make the call with your full portfolio in view.